Sarkar Mihir, Sinha Rajasree, Roychowdhoury Satyabrata, Mukhopadhyay Sobhanman, Ghosh Pramit, Dutta Kalpana, Ghosh Shibarjun
Department of Pediatrics, Medical College and Hospital, Kolkata, West Bengal, India.
Department of Community Medicine, Medical College and Hospital, Kolkata, West Bengal, India.
Indian J Crit Care Med. 2018 Feb;22(2):85-90. doi: 10.4103/ijccm.IJCCM_274_17.
Early initiation of appropriate noninvasive respiratory support is utmost important intervention to avoid mechanical ventilation in severe bronchiolitis.
This study aims to compare noninvasive continuous positive airway pressure (nCPAP) and hot humidified high-flow nasal cannulae (HHHFNC) as modes of respiratory support in infants with severe bronchiolitis.
Prospective, randomized, open-label pilot study done in a tertiary-care hospital Pediatric Intensive Care Unit (PICU). Participants: 31 infants (excluding neonates) clinically diagnosed with acute bronchiolitis having peripheral capillary oxygen saturation (SpO) <92% (with room air oxygen); Respiratory Distress Assessment Index (RDAI) ≥11. Intervention: nCPAP ( = 16) or HHHFNC ( = 15), initiated at enrollment. Primary outcome: Reduction of need of mechanical ventilation assessed by improvements in (i) SpO% (ii) heart rate (HR); respiratory rate; (iii) partial pressure of carbon dioxide; (iv) partial pressure of oxygen; (v) COMFORT Score; (vi) RDAI from preintervention value. Secondary outcome: (i) total duration of noninvasive ventilation support; (ii) PICU length of stay; and (iii) incidence of nasal injury (NI).
Mean age was 3.41 ± 1.11 months (95% confidence interval 2.58-4.23). Compared to nCPAP, HHHFNC was better tolerated as indicated by better normalization of HR ( < 0.001); better COMFORT Score ( < 0.003) and lower incidence of NI (46.66% vs. 75%; = 0.21). Improvements in other outcome measures were comparable for both groups. For both methods, no major patient complications occurred.
HHHFNC is an emerging alternative to nCPAP in the management of infants with acute bronchiolitis.
尽早开始适当的无创呼吸支持是避免重症细支气管炎患者接受机械通气的极为重要的干预措施。
本研究旨在比较无创持续气道正压通气(nCPAP)和温热湿化高流量鼻导管吸氧(HHHFNC)作为重症细支气管炎婴儿呼吸支持模式的效果。
在一家三级医院的儿科重症监护病房(PICU)进行前瞻性、随机、开放标签的试点研究。参与者:31名临床诊断为急性细支气管炎的婴儿(不包括新生儿),外周毛细血管血氧饱和度(SpO)<92%(吸入室内空气氧);呼吸窘迫评估指数(RDAI)≥11。干预措施:nCPAP(n = 16)或HHHFNC(n = 15),在入组时开始使用。主要结局:通过以下指标的改善评估机械通气需求的减少:(i)SpO%;(ii)心率(HR)、呼吸频率;(iii)二氧化碳分压;(iv)氧分压;(v)舒适度评分;(vi)与干预前值相比的RDAI。次要结局:(i)无创通气支持的总持续时间;(ii)PICU住院时间;(iii)鼻损伤(NI)的发生率。
平均年龄为3.41±1.11个月(95%置信区间2.58 - 4.23)。与nCPAP相比,HHHFNC耐受性更好,表现为HR更好地恢复正常(P<0.001);舒适度评分更好(P<0.003),NI发生率更低(46.66%对75%;P = 0.21)。两组在其他结局指标上的改善相当。两种方法均未发生重大患者并发症。
在急性细支气管炎婴儿的管理中,HHHFNC是nCPAP的一种新兴替代方法。